{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:43:38Z","timestamp":1780321418097,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41375-021-01500-1","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T14:02:41Z","timestamp":1640181761000},"page":"562-565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-2503","authenticated-orcid":false,"given":"Sibylle C.","family":"Mellinghoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Robrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7102-4358","authenticated-orcid":false,"given":"Leonie","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1175-7354","authenticated-orcid":false,"given":"Leonie M.","family":"Weskamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-9195","authenticated-orcid":false,"given":"Christine","family":"Dahlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0725-7138","authenticated-orcid":false,"given":"Henning","family":"Gruell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Vanshylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans A.","family":"Schl\u00f6sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2785-9726","authenticated-orcid":false,"given":"Martin","family":"Thelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-7890","authenticated-orcid":false,"given":"Anna-Maria","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-9224","authenticated-orcid":false,"given":"Marylyn M.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Eichhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6654-0304","authenticated-orcid":false,"given":"Petra","family":"Langerbeins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"1500_CR1","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1038\/s41375-021-01450-8","volume":"35","author":"T Chatzikonstantinou","year":"2021","unstructured":"Chatzikonstantinou T, Kapetanakis A, Scarf\u00f2 L, Karakatsoulis G, Allsup D, Cabrero AA, et al. COVID-19 severity and mortality in patients with CLL: An update of the international ERIC and Campus CLL study. Leukemia. 2021;35:3444\u201354.","journal-title":"Leukemia"},{"key":"1500_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/vaccines9030238","volume":"9","author":"T Koch","year":"2021","unstructured":"Koch T, Mellinghoff SC, Shamsrizi P, Addo MM, Dahlke C. Correlates of vaccine-induced protection against SARS-CoV-2. Vaccines. 2021;9:238.","journal-title":"Vaccines"},{"key":"1500_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","volume":"587","author":"J Braun","year":"2020","unstructured":"Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587:270\u20134.","journal-title":"Nature."},{"key":"1500_CR4","doi-asserted-by":"publisher","unstructured":"Benjamini O, Rokach L, Itchaki G, Braester A, Shvidel L, Goldschmidt N, et al. Safety and efficacy of BNT162b mRNA Covid19 Vaccine in patients with chronic lymphocytic leukemia. Haematologica. 2021. https:\/\/doi.org\/10.3324\/haematol.2021.279196. Epub ahead of print.","DOI":"10.3324\/haematol.2021.279196"},{"key":"1500_CR5","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood.2021011568","volume":"137","author":"Y Herishanu","year":"2021","unstructured":"Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137:3165\u201373.","journal-title":"Blood."},{"key":"1500_CR6","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1038\/s41375-021-01380-5","volume":"35","author":"T Tadmor","year":"2021","unstructured":"Tadmor T, Benjamini O, Braester A, Rahav G, Rokach L. Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia. Leukemia. 2021;35:2727\u201330.","journal-title":"Leukemia."},{"key":"1500_CR7","first-page":"136","volume":"11","author":"H Parry","year":"2021","unstructured":"Parry H, McIlroy G, Bruton R, Ali M, Stephens C, Damery S, et al. Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia. Blood. Cancer J. 2021;11:136.","journal-title":"Cancer J"},{"key":"1500_CR8","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ccell.2021.07.016","volume":"39","author":"S Ehmsen","year":"2021","unstructured":"Ehmsen S, Asmussen A, Jeppesen SS, Nilsson AC, \u00d8sterlev S, Vestergaard H, et al. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Cancer Cell. 2021;39:1034\u20136.","journal-title":"Cancer Cell"},{"key":"1500_CR9","doi-asserted-by":"publisher","unstructured":"Pozzetto B, Legros V, Djebali S, Barateau V, Guibert N, Villard M, et al. Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-021-04120-y. Epub ahead of print.","DOI":"10.1038\/s41586-021-04120-y"},{"key":"1500_CR10","doi-asserted-by":"publisher","unstructured":"da Cunha-Bang C, Kirkby NS, Friis-Hansen L, Niemann CU. Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2021:1\u20133. https:\/\/doi.org\/10.1080\/10428194.2021.1973673. Epub ahead of print.","DOI":"10.1080\/10428194.2021.1973673"},{"key":"1500_CR11","doi-asserted-by":"publisher","first-page":"1910\u20136.","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910\u20136.","journal-title":"N Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01500-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01500-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01500-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T09:10:28Z","timestamp":1643706628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01500-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1500"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01500-1","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,22]]},"assertion":[{"value":"8 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SCM reports grants from DZIF (Clinical Leave Stipend). AMF reports research funding from Celgene\/Bristol Myers Squibb (Inst), AstraZeneca (Inst), and travel Expenses by AbbVie. KF reports other from Roche, other from AbbVie. BE reports grants and personal fees from Janssen-Cilag, grants and personal fees from Roche, personal fees from Novartis, grants and personal fees from AbbVie, personal fees from Celgene, personal fees from ArQule, personal fees from AstraZeneca, personal fees from Oxford Biomedica (UK), grants and personal fees from Gilead, grants from BeiGene, outside the submitted work. MH reports other from AbbVie, other from F. Hoffman-LaRoche, other from Gilead, other from Janssen-Cilag, other from Mundipharma, during the conduct of the study. PL reports grants and personal fees from Janssen-Cilag, personal fees from Abbvie, other from F. Hoffman-LaRoche, personal fees from AstraZeneca. The remaining authors declare no competing financial interests for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}